Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection
Hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide, with 75% of those affected distributed in the Asia-Pacific region. Approximately one million HBV-infected patients die of liver cirrhosis and hepatocellular carcinoma (HCC) each year. If left untreated, 6–20% of chronic...
Main Author: | Lu, Lun-Gen |
---|---|
Format: | Online |
Language: | English |
Published: |
XIA & HE Publishing Ltd
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521245/ |
Similar Items
-
Liver biopsy interpretation & the regression of hepatitis B virus related cirrhosis
by: Grizzi, Fabio, et al.
Published: (2014) -
Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
by: Hoang, Joseph K., et al.
Published: (2016) -
Treatment of Hepatitis B Virus Cirrhosis
by: Rizzetto, Mario
Published: (2012) -
EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2014-01-01) -
Occult Hepatitis C Virus Infection in Candidates for Liver Transplant With Cryptogenic Cirrhosis
by: Keyvani, Hossein, et al.
Published: (2013)